Coronary artery bypass grafting (CABG): reassessing efficacy, safety, and cost

Area of Science:

• Cardiology
• Clinical Trials
• Health Services Research

Background:

• Coronary artery bypass grafting (CABG) has been a standard treatment for coronary artery disease (CAD) since the 1970s, based on early trials demonstrating its superiority over medical management.
• Extensive research has since explored CAD pathogenesis, CABG efficacy, risks, costs, and the impact of risk factor reduction.

Purpose of the Study:

• To re-evaluate the efficacy, safety, and cost-effectiveness of CABG in managing coronary artery disease (CAD).
• To investigate the relationship between the extent of revascularization and patient outcomes.
• To explore the role of coronary risk factor reduction in angina relief and survival.

Main Methods:

• A MEDLINE search identified randomized trials comparing CABG with nonsurgical management, CAD pathogenesis studies, and risk factor reduction efficacy articles.
• Analysis focused on randomized trials comparing CABG versus medical management.
• The Bypass Angioplasty Revascularization Intervention (BARI) study data, including lifestyle factors, was considered for multivariate analysis.

Main Results:

• The extent of revascularization during CABG did not correlate with angina relief or improved survival.
• Improved survival with CABG was observed only in patients with advanced CAD, and this benefit disappeared after 12 years.
• Factors beyond revascularization, such as lifestyle changes and risk factor reduction, appear to contribute to angina improvement and potential survival advantages.

Conclusions:

• CABG's survival advantage is limited to specific patient subgroups with advanced CAD and is not sustained long-term.
• Risk factor reduction and lifestyle modifications play a crucial role in managing CAD, potentially explaining some benefits attributed solely to revascularization.
• Further analysis, incorporating lifestyle factors, is needed to fully understand the determinants of survival and quality of life in CAD patients treated with CABG.